“…The expanding ozone holes in the atmosphere lead to the growing danger of UV skin damage, making the pharmaceutical industry increase the production of new types of sun protection (Smit et al, 2009;Zastrow et al, 2017), which requires the new systems for testing them in vitro. At present, the mainly used testsystems are primary cultures of melanocytes and keratinocytes (Lei et al, 2002;Lee et al, 2020), melanoma cell lines (Kim et al, 2017;Lee et al, 2020), the commercial tissue equivalents (EpiSkin TM , MelanoDerm TM , and others) (Costin and Raabe, 2013;Kim et al, 2017;Meena and Mohandass, 2019;Lee et al, 2020), and tissue equivalents obtained from cells with induced pluripotency (iPSC) (Gledhill et al, 2015). These approaches have some limitations, including non-physiological conditions (for 2D cultures), difficulties in analysis, and expensiveness (for commercial tissue equivalents).…”